## STZ: Constellation Brands, Inc. - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.4% in mid entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (3.0%) confirms momentum alignment. Strong momentum (+2.9% 5-day acceleration). Outperforming sector by 8.5%. Caution: overbought RSI (78).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($143.25)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Diageo plc $DEO Shares Bought by Federated Hermes Inc.**
- Source: MarketBeat | 20251209T031008 | Neutral | Relevance: 64%
- Federated Hermes Inc. increased its stake in Diageo plc (NYSE:DEO) by 7.3% during the second quarter, valuing its holdings at approximately $68.34 million. Despite this, analyst sentiment remains mixed-to-negative, with an average rating of "Reduce" and a consensus target price of $119. The company's stock currently trades at $88.38, below its 50-day and 200-day simple moving averages, reflecting recent downward trends and analyst downgrades.

**2. Life360 director Coghlan sells $241k in shares By Investing.com**
- Source: Investing.com Australia | 20251210T020924 | Somewhat-Bullish | Relevance: 63%
-  John Philip Coghlan, a director at Life360, Inc., recently sold 3,125 shares of the company's common stock for approximately $241,316. The sales were executed under a pre-arranged Rule 10b5-1 trading plan. The company's stock has shown significant returns year-to-date and over the past year, though InvestingPro's Fair Value estimate suggests it might be overvalued.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-21 | Piper Sandler | $135 | $155 | -13% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-21 | Piper Sandler | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.5% (+3.2%)
- Berkshire Hathaway, : 7.7% (0.0%)
- Blackrock Inc.: 6.1% (-2.0%)
- Capital World Invest: 3.8% (-43.3%)
- State Street Corpora: 3.8% (-4.2%)

### Key Risks

1. Long-term trend broken: trading 7.7% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Momentum building: MRS_20 improving +2.9% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.58 elevated, pricing in significant growth expectations. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bearish (6 selling vs 3 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $26.0B |
| Beta | 0.46 |
| 52W Range | $126.45 - $242.64 |
| Short Interest | 6.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.58 |
| Forward P/E | 12.0 |
| Current P/E | 13.0 |
| YoY Growth | 8.0% |
| EPS Direction | FALLING |

### Technicals

MRS_20 strengthening from 4.5% to 7.4% (+2.9% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 3.0% confirms short-term momentum alignment. AM_20 at 9.7% shows strong absolute momentum above own 20MA. Outperforming sector by 8.5pp, stock-specific strength. Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (1.79), confirming momentum. RSI overbought at 78, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.40% (CS: 88) | Strong |
| RSI_14 | 78.0 | Overbought |
| MACD Histogram | 1.79 | Bullish |
| vs SMA20 | 1.097x | Above |
| vs SMA50 | 1.096x | Above |
| vs SMA200 | 0.923x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $149.55
- **Stop Loss:** $143.25 (4.2% risk)
- **Target:** $159.00 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 219
- **Position Value:** $32,751.45
- **Portfolio %:** 32.75%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-07 (Est: $2.65)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.41 | $3.63 | +6.5% |
| 2025Q2 | $3.29 | $3.22 | -2.3% |
| 2025Q1 | $2.27 | $2.63 | +15.9% |
| 2024Q4 | $3.31 | $3.25 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*